Skip to content

Clinical trials

Phase 2 Gastrointestinal Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Phase: Phase 2 Country / region: United States Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20043
20062
20071
20091
20102
20122
20131
20142
20152
20161
20172
20181
20193
20201
20214
20221
20234
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated8
Recruiting7
Active, not recruiting4
Unknown status2
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center6
National Cancer Institute (NCI)5
National Institutes of Health Clinical Center (CC)2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
Abramson Cancer Center at Penn Medicine1
Ariad Pharmaceuticals1
Bay Area Gynecology Oncology1
Bayer1
BioMed Valley Discoveries, Inc1
Brigham and Women's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms42
Colorectal Neoplasms10
Neoplasms8
Breast Neoplasms7
Ovarian Neoplasms6
Pancreatic Neoplasms6
Esophageal Neoplasms5
Neoplasm Metastasis5
Biliary Tract Neoplasms4
Carcinoma, Hepatocellular4

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.